blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1490071

EP1490071 - THERAPEUTIC USES OF SAPOGENINS [Right-click to bookmark this link]
Former [2005/01]THERAPUTIC METHODS AND USES OF SAPOGENINS AND THEIR DERIVATIVES
[2008/28]
StatusNo opposition filed within time limit
Status updated on  08.01.2010
Database last updated on 03.10.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
PHYTOPHARM PLC
Corpus Christi House, 9 West Street Godmanchester
Cambridgeshire PE18 2HY / GB
[2009/10]
Former [2005/01]For all designated states
Phytopharm Plc
Corpus Christi House, 9 West Street
Godmanchester, Cambridgeshire PE18 2HY / GB
Inventor(s)01 / REES, Daryl
9,West Street
Godmanchester, Cambridgeshire PE29 2HY / GB
02 / GUNNING, Phil
9,West Street
Godmanchester, Cambridgeshire PE29 2HY / GB
03 / ORSI, Antonia
9,West Street
Godmanchester, Cambridgeshire PE29 2HY / GB
04 / XIA, Zongqin
Flat 403, Block 8 1, Jian-De Road
Shanghai 200025 / CN
05 / HU, Yaer
Flat 1209, Block1, Lane 357, MaDang Road
Shanghai 200025 / CN
 [2005/01]
Representative(s)Brown, David Leslie
Haseltine Lake Kempner LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
[N/P]
Former [2005/01]Brown, David Leslie
HASELTINE LAKE, Redcliff Quay 120 Redcliff Street
Bristol BS1 6HU / GB
Application number, filing date03722713.927.03.2003
[2005/01]
WO2003GB01380
Priority number, dateAR2002P10117027.03.2002         Original published format: AR P020101170
US20020368178P28.03.2002         Original published format: US 368178 P
WO2002GB0157828.03.2002         Original published format: PCT/GB02/01578
[2009/09]
Former [2005/01]AR2001000117027.03.2002
US20020368178P28.03.2002
WO2002GB0157828.03.2002
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03082893
Date:09.10.2003
Language:EN
[2003/41]
Type: A2 Application without search report 
No.:EP1490071
Date:29.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Type: B1 Patent specification 
No.:EP1490071
Date:04.03.2009
Language:EN
[2009/10]
Search report(s)International search report - published on:EP15.04.2004
ClassificationIPC:A61K31/585, A61P9/02, A61P9/04, A61P11/06, A61P21/00, A61P21/04, A61P25/08, A61P25/16, A61P25/28, A61P27/00
[2005/01]
CPC data not yet available
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
Extension statesAL22.12.2004
LT22.12.2004
LV22.12.2004
MK22.12.2004
TitleGerman:THERAPEUTISCHE VERWENDUNG VON SAPOGENINEN[2008/28]
English:THERAPEUTIC USES OF SAPOGENINS[2008/28]
French:UTILISATIONS THERAPEUTIQUES DES SAPOGENINES[2008/28]
Former [2005/01]THERAPEUTISCHE VERFAHREN UND VERWENDUNG VON SAPOGENINEN UND DEREN DERIVATE
Former [2005/01]THERAPUTIC METHODS AND USES OF SAPOGENINS AND THEIR DERIVATIVES
Former [2005/01]METHODES THERAPEUTIQUES ET UTILISATIONS DES SAPOGENINES ET DE LEURS DERIVES
Entry into regional phase21.10.2004National basic fee paid 
21.10.2004Designation fee(s) paid 
21.10.2004Examination fee paid 
Examination procedure22.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.10.2004Examination requested  [2004/53]
16.01.2006Despatch of a communication from the examining division (Time limit: M06)
01.09.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.10.2006Reply to a communication from the examining division
05.06.2007Despatch of a communication from the examining division (Time limit: M04)
05.09.2007Reply to a communication from the examining division
16.10.2007Despatch of a communication from the examining division (Time limit: M02)
17.12.2007Reply to a communication from the examining division
21.08.2008Communication of intention to grant the patent
29.12.2008Fee for grant paid
29.12.2008Fee for publishing/printing paid
Divisional application(s)EP09154213.4  / EP2111864
Opposition(s)07.12.2009No opposition filed within time limit [2010/06]
Request for further processing for:18.10.2006Request for further processing filed
25.10.2006Full payment received (date of receipt of payment)
Request granted
10.11.2006Decision despatched
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
29.03.2006Renewal fee patent year 04
28.03.2007Renewal fee patent year 05
27.03.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY04.03.2009
CZ04.03.2009
DK04.03.2009
EE04.03.2009
RO04.03.2009
SI04.03.2009
SK04.03.2009
TR04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
HU05.09.2009
[2011/44]
Former [2011/31]CZ04.03.2009
DK04.03.2009
EE04.03.2009
RO04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
HU05.09.2009
Former [2010/48]CZ04.03.2009
DK04.03.2009
EE04.03.2009
RO04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
GR05.06.2009
Former [2010/08]CZ04.03.2009
DK04.03.2009
EE04.03.2009
RO04.03.2009
SI04.03.2009
SK04.03.2009
BG04.06.2009
SE04.06.2009
Former [2009/50]CZ04.03.2009
EE04.03.2009
RO04.03.2009
SI04.03.2009
SK04.03.2009
SE04.06.2009
Former [2009/49]CZ04.03.2009
EE04.03.2009
SI04.03.2009
SE04.06.2009
Former [2009/39]SI04.03.2009
SE04.06.2009
Former [2009/36]SI04.03.2009
Cited inInternational search[A]JPH05246866  ;
 [X]JP2002030096  ;
 [A]JPH092957  ;
 [A]JPH092956  ;
 [X]EP0162330  (ROECAR HOLDINGS NV [NL]) [X] 1,2,4-8 * page 5, paragraph 2 - paragraph 3 * * claim 3 *;
 [X]US4680289  (APPLEZWEIG NORMAN [US]) [X] 5 * tables I,II * * claims 16,18,19 *;
 [XD]DE4303214  (MARKS WOLFGANG [DE]) [XD] 1-8 * page 6, line 15 - line 26 * * page 7, line 10 - line 15 * * claims 1-3,7,14 *;
 [A]EP0659762  (MITSUBISHI CHEM CORP [JP]) [A] 1-8 * page 108, line 23 - line 36 * * claims 1,3,27 *;
 [A]WO9802450  (INFLAZYME PHARM LTD [CA]) [A] 1-8 * example 25 * * page 178, line 9 - line 10 * * claims 27,29 *;
 [XD]WO9948507  (PHYTOPHARM PLC [GB], et al) [XD] 1-8 * page 1, line 5 - line 24 * * page 7, line 6 - page 8, line 4 * * page 9, line 5 - line 13 * * page 10, line 4 - line 11 * * page 15, line 9 - page 16, line 3 * * page 23, line 23 - page 24, line 8 * * claims 1-32 *;
 [X]EP1024146  (INST RADIATION MED AMMS PLA [CN]) [X] 1-7 * page 19, line 11 - line 12 * * page 33, line 46 - page 34, line 27 * * claims 1,3-20 *;
 [XD]WO0123406  (PHYTOPHARM PLC [GB], et al) [XD] 1-8 * page 1, line 4 - line 33 * * page 6, line 17 - page 9, line 17 * * page 13, line 4 - line 23 * * page 13, line 28 - line 30 * * page 15 - page 19; table 1 * * claims 1-15 *;
 [XD]WO0123408  (PHYTOPHARM PLC [GB], et al) [XD] 1-8 * page 1, line 4 - line 22 * * page 6, line 16 - page 9, line 17 * * page 12, line 16 - line 24 * * page 13, line 16 - page 14, line 27 * * claims 1-13 *;
 [X]WO0123407  (PHYTOPHARM PLC [GB], et al) [X] 1,2,5-8 * page 6, line 20 - page 8, line 32 * * claims 1-5,8,14 *;
 [X]WO0149703  (PHYTOPHARM PLC [GB], et al) [X] 1-8 * page 1, line 1 - line 22 * * page 7, line 11 - page 15, line 4 * * page 15, line 6 - page 16, line 24 * * page 22, line 32 - line 34 * * page 23, line 3 - line 35 * * claims 1-20,22,26,28,29 *;
 [E]WO03077869  (SAMARITAN PHARMACEUTICALS INC [US], et al) [E] 1,2,4-8 * figure 1 * * page 5, line 14 - line 21 ** claims 1-8,10-14 *;
 [X]  - SUN, HUI ET AL, "Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease", JOURNAL OF BIOLOGICAL CHEMISTRY (1999), 274(12), 8269-8281, XP001165795 [X] 1-3,5,8 * figures 2,3,9,10 * * page 8280, column 2, paragraph 3 *

DOI:   http://dx.doi.org/10.1074/jbc.274.12.8269
 [A]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 1993, no. 43, Database accession no. 1993-339641, XP002157713 & JPH05246866 A 19930924 (KATO K) [A] 1-8 * abstract *
 [X]  - PATENT ABSTRACTS OF JAPAN, (20020503), vol. 2002, no. 05, & JP2002030096 A 20020129 (KYORIN PHARMACEUT CO LTD) [X] 1,2,5-8 * abstract *
 [A]  - PATENT ABSTRACTS OF JAPAN, (19970530), vol. 1997, no. 05, & JP09002957 A 19970107 (MITSUBISHI CHEM CORP) [A] 1-8 * abstract *
 [A]  - PATENT ABSTRACTS OF JAPAN, (19970530), vol. 1997, no. 05, & JP09002956 A 19970107 (MITSUBISHI CHEM CORP) [A] 1-8 * abstract *
 [A]  - INOUE K ET AL, "Cholestanol induces apoptosis of cerebellar neuronal cells.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. UNITED STATES 5 MAR 1999, (19990305), vol. 256, no. 1, ISSN 0006-291X, pages 198 - 203, XP001188107 [A] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.1998.9497
 [A]  - KYOUNG SOOK KIM, ET AL., "Effects of cholestanol feeding on corneal dystrophy in mice.", BIOCHIMICA ET BIOPHYSICA ACTA, (1991), vol. 1085, pages 343 - 349, XP008027217 [A] 1-8 * the whole document *
Examination   - NICOLAUS B.J.R., Decision Making in Drug Research, NEW YORK, USA, RAVEN PRESS, (1983) * "Symbiotic Approach to Drug Design"; page 173 - page 186 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.